Health and Wellness Market in China 2021
- Market Report
- ID: HL10072C
- Delivery Time: 1 Business Day
- Tag: Health and Wellness
Description
The health and wellness market in China in terms of revenue is set to grow by US$ 1,044 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.4% during the forecast period, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for health and wellness. The China health and wellness market is segmented on the basis of type. By type, it is categorized into consumer healthcare, healthcare infrastructure, healthcare services, non-pharmaceutical product, and pharmaceutical.
The report has profiled some of the key players of the market such as Ikang Healthcare Group Inc., Jiangsu Hengrui Medicine Co. Ltd., Meinian Onehealth Healthcare Holdings Co. Ltd., Ping An Health Insurance Company of China Ltd., Shanghai Pharmaceuticals Holding Co. Ltd., Sino Biopharmaceutical Limited, Yunnan Baiyao Group Co. Ltd..
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the health and wellness market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Type: consumer healthcare, healthcare infrastructure, healthcare services, non-pharmaceutical product, and pharmaceutical
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the China health and wellness market
Pinpoint growth sectors and trends for investment
Understand what the future of the health and wellness market in China looks like
Identify the competitive landscape and window of opportunity
Table of Contents
1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Health and Wellness Market by Type
4.1 Consumer Healthcare
4.2 Healthcare Infrastructure
4.3 Healthcare Services
4.4 Non-Pharmaceutical Product
4.5 Pharmaceutical
5. Company Profiles
5.1 Ikang Healthcare Group, Inc.
5.2 Jiangsu Hengrui Medicine Co., Ltd.
5.3 Meinian Onehealth Healthcare Holdings Co., Ltd.
5.4 Ping An Health Insurance Company of China, Ltd.
5.5 Shanghai Pharmaceuticals Holding Co., Ltd.
5.6 Sino Biopharmaceutical Limited
5.7 Yunnan Baiyao Group Co., Ltd.
6. Appendix
6.1 About StrategyHelix
6.2 Disclaimer
USD 450